| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Humer Franz B is a Director at Allogene Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $3.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2024 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 9,221 | $2.16 | $19,917.36 | -2.9% | -9.8% | -33.2% | |
| May 30, 2024 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 11,200 | $2.34 | $26,181.12 | -4.2% | +4.5% | -52.4% | |
| Oct 15, 2018 | ALLO Allogene Therapeutics, Inc. | Director | Buy | 30,000 | $18.00 | $540,000.00 | New | - | - |